Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06358755 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date changed from estimate of May 30, 2026 to Apr 25, 2026
    • Eligibility criteria expanded, about 21 words
    • Publications: details revised at 1 of 1 entry
  2. Minor Re-verified, no change to tracked fieldsv7
  3. Minor Primary completion date: Apr 30, 2026 to May 30, 2026
    • Study completion date: Oct 31, 2026 to Jan 31, 2027
    v6
  4. Minor Re-verified, no change to tracked fieldsv5
  5. Notable Phase: Phase 2 to Not applicable
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2024 to Jul 12, 2024
    • Site details revised
    v3
  2. Notable Start date: May 1, 2024 to Jul 1, 2024v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to investigate the combination effect of optical defocus and low dose atropine on myopia control in schoolchildren.
Trial Details
NCT Number NCT06358755
Lead Sponsor The Hong Kong Polytechnic University
Collaborators: The University of Hong Kong
Conditions
(from sponsor)
Myopia
Related terms Myopia
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov